PortalPublikationenReal-world data on the effectiveness, safety and drug surviv...

Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

Standard

Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. / Stölzl, Dora; Sander, Nicole; Heratizadeh, Annice; Haufe, Eva; Harder, Inken; Abraham, Susanne; Heinrich, Luise; Kleinheinz, Andreas; Wollenberg, Andreas; Weisshaar, Elke; Schäkel, Knut; Ertner, Konstantin; Wiemers, Franca; Wildberger, Julia; Worm, Margitta; von Kiedrowski, Ralph; Effendy, Isaak; Asmussen, Andrea; Augustin, Matthias; Pawlak, Mario; Sticherling, Michael; Zink, Alexander; Hilgers, Melanie; Handrick, Christiane; Quist, Sven; Schwarz, Beate; Staubach-Renz, Petra; Bell, Magnus; Hong-Weldemann, Sun-Hei; Homey, Bernhard; Brücher, Jens-Joachim; Schmitt, Jochen; Werfel, Thomas; Weidinger, Stephan; TREATgermany study group.

in: BRIT J DERMATOL, Jahrgang 187, Nr. 6, 12.2022, S. 1022-1024.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Stölzl, D, Sander, N, Heratizadeh, A, Haufe, E, Harder, I, Abraham, S, Heinrich, L, Kleinheinz, A, Wollenberg, A, Weisshaar, E, Schäkel, K, Ertner, K, Wiemers, F, Wildberger, J, Worm, M, von Kiedrowski, R, Effendy, I, Asmussen, A, Augustin, M, Pawlak, M, Sticherling, M, Zink, A, Hilgers, M, Handrick, C, Quist, S, Schwarz, B, Staubach-Renz, P, Bell, M, Hong-Weldemann, S-H, Homey, B, Brücher, J-J, Schmitt, J, Werfel, T, Weidinger, S & TREATgermany study group 2022, 'Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry', BRIT J DERMATOL, Jg. 187, Nr. 6, S. 1022-1024. https://doi.org/10.1111/bjd.21794

APA

Stölzl, D., Sander, N., Heratizadeh, A., Haufe, E., Harder, I., Abraham, S., Heinrich, L., Kleinheinz, A., Wollenberg, A., Weisshaar, E., Schäkel, K., Ertner, K., Wiemers, F., Wildberger, J., Worm, M., von Kiedrowski, R., Effendy, I., Asmussen, A., Augustin, M., ... TREATgermany study group (2022). Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. BRIT J DERMATOL, 187(6), 1022-1024. https://doi.org/10.1111/bjd.21794

Vancouver

Stölzl D, Sander N, Heratizadeh A, Haufe E, Harder I, Abraham S et al. Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. BRIT J DERMATOL. 2022 Dez;187(6):1022-1024. https://doi.org/10.1111/bjd.21794

Bibtex

@article{793b78c6487e450f8b68d40aa885608e,
title = "Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry",
abstract = "This interim analysis from the atopic dermatitis registry TREATgermany shows robust long-term efficacy, favourable safety and high persistence of dupilumab under real life conditions.",
keywords = "Humans, Severity of Illness Index, Treatment Outcome, Antibodies, Monoclonal, Humanized/adverse effects, Registries",
author = "Dora St{\"o}lzl and Nicole Sander and Annice Heratizadeh and Eva Haufe and Inken Harder and Susanne Abraham and Luise Heinrich and Andreas Kleinheinz and Andreas Wollenberg and Elke Weisshaar and Knut Sch{\"a}kel and Konstantin Ertner and Franca Wiemers and Julia Wildberger and Margitta Worm and {von Kiedrowski}, Ralph and Isaak Effendy and Andrea Asmussen and Matthias Augustin and Mario Pawlak and Michael Sticherling and Alexander Zink and Melanie Hilgers and Christiane Handrick and Sven Quist and Beate Schwarz and Petra Staubach-Renz and Magnus Bell and Sun-Hei Hong-Weldemann and Bernhard Homey and Jens-Joachim Br{\"u}cher and Jochen Schmitt and Thomas Werfel and Stephan Weidinger and {TREATgermany study group}",
note = "{\textcopyright} 2022 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.",
year = "2022",
month = dec,
doi = "10.1111/bjd.21794",
language = "English",
volume = "187",
pages = "1022--1024",
journal = "BRIT J DERMATOL",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

AU - Stölzl, Dora

AU - Sander, Nicole

AU - Heratizadeh, Annice

AU - Haufe, Eva

AU - Harder, Inken

AU - Abraham, Susanne

AU - Heinrich, Luise

AU - Kleinheinz, Andreas

AU - Wollenberg, Andreas

AU - Weisshaar, Elke

AU - Schäkel, Knut

AU - Ertner, Konstantin

AU - Wiemers, Franca

AU - Wildberger, Julia

AU - Worm, Margitta

AU - von Kiedrowski, Ralph

AU - Effendy, Isaak

AU - Asmussen, Andrea

AU - Augustin, Matthias

AU - Pawlak, Mario

AU - Sticherling, Michael

AU - Zink, Alexander

AU - Hilgers, Melanie

AU - Handrick, Christiane

AU - Quist, Sven

AU - Schwarz, Beate

AU - Staubach-Renz, Petra

AU - Bell, Magnus

AU - Hong-Weldemann, Sun-Hei

AU - Homey, Bernhard

AU - Brücher, Jens-Joachim

AU - Schmitt, Jochen

AU - Werfel, Thomas

AU - Weidinger, Stephan

AU - TREATgermany study group

N1 - © 2022 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

PY - 2022/12

Y1 - 2022/12

N2 - This interim analysis from the atopic dermatitis registry TREATgermany shows robust long-term efficacy, favourable safety and high persistence of dupilumab under real life conditions.

AB - This interim analysis from the atopic dermatitis registry TREATgermany shows robust long-term efficacy, favourable safety and high persistence of dupilumab under real life conditions.

KW - Humans

KW - Severity of Illness Index

KW - Treatment Outcome

KW - Antibodies, Monoclonal, Humanized/adverse effects

KW - Registries

U2 - 10.1111/bjd.21794

DO - 10.1111/bjd.21794

M3 - Other (editorial matter etc.)

C2 - 35895855

VL - 187

SP - 1022

EP - 1024

JO - BRIT J DERMATOL

JF - BRIT J DERMATOL

SN - 0007-0963

IS - 6

ER -